SWP
MDCO

Stratos Wealth Partners’s Medicines Co MDCO Stock Holding History

Stratos Wealth Partners’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-400
Closed -$13K – 2967
2018
Q1 		$13K Sell
400
-1,000
-71% -$31.2K ﹤0.01% 2207
2017
Q4 		$38K Buy
+1,400
New +$43.1K ﹤0.01% 1655

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Stratos Wealth Partners's MDCO Position: Q2 2018 in Review

Stratos Wealth Partners sold out of Medicines Co (MDCO) in Q2 2018, closing a stake of 400 shares — an estimated $13K sold.

Stratos Wealth Partners first reported a position in MDCO in Q4 2017 and held it in 2 quarters. The position peaked at $38K in Q4 2017. 188 funds tracked by Wall St. Rank hold MDCO as of Q2 2018.

  • Stratos Wealth Partners reported no remaining Medicines Co position as of Q2 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 400 Medicines Co shares in Q2 2018, an estimated $13K.
  • Stratos Wealth Partners first reported a position in Medicines Co in Q4 2017 and held it in 2 quarters.
  • Stratos Wealth Partners's Medicines Co position peaked at $38K in Q4 2017.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q2 2018.

Based on Stratos Wealth Partners's 13F filing for Q2 2018, filed 13 Aug 2018.